CELEX:62020CA0224: Case C-224/20: Judgment of the Court (Fifth Chamber) of 17 November 2022 (request for a preliminary ruling from the Sø- og Handelsretten — Denmark) — Merck Sharp & Dohme BV, Merck Sharp & Dohme Corp., MSD Danmark ApS v Abacus Medicine A/S, and Novartis AG v Abacus Medicine A/S, and Novartis AG v Abacus Medicine A/S, and Novartis AG v Paranova Danmark A/S, and H. Lundbeck A/S v Paranova Danmark A/S, and MSD Danmark ApS, MSD Sharp & Dohme GmbH, Merck Sharp & Dohme Corp. v 2CARE4 ApS, and Ferring Lægemidler A/S v Paranova Danmark A/S (Reference for a preliminary ruling — Articles 34 and 36 TFEU — Free movement of goods — Intellectual property — Trade marks — Regulation (EU) 2017/1001 — EU trade mark — Article 9(2) — Article 15 — Directive (EU) 2015/2436 — Approximation of the laws of the Member States relating to trade marks — Article 10(2) — Article 15 — Rights conferred by a trade mark — Exhaustion of the rights conferred by a trade mark — Parallel import of medicinal products — Repackaging of the product bearing the mark — New outer packaging — Replacement of the trade mark appearing on the original outer packaging by another product name — Reaffixing of the trade mark of the proprietor specific to the product, to the exclusion of the other distinctive marks or signs appearing on that original outer packaging — Opposition by the proprietor of the mark — Artificial partitioning of the markets between Member States — Medicinal products for human use — Directive 2001/83/EC — Article 47a — Safety features — Replacement — Equivalent features — Delegated Regulation (EU) 2016/161 — Article 3(2) — Anti-tampering device)
16 January, 2023
No Comments